http://www.fpnotebook.com/
Gestational Diabetes Management
- Indications: Gestational Diabetes
- Abnormal Glucose Tolerance Test 3 hour
- Preexisting Diabetes Mellitus
- Blood Glucose Monitoring
- Frequency of Blood Glucose Monitoring
- Insulin therapy: qid Blood Sugar Monitoring
- Diet control: qid blood sugars on 2 days per week
- Increase monitoring if 2 values/week abnormal
- Target Levels
- Before Breakfast: 60 to 90 mg/dl
- Before Lunch,Dinner: 60 to 115 mg/dl
- Early morning (2-6 am): 60 to 90 mg/dl
- Check Urine Ketones in early morning
- Two hour post prandial: under 120 mg/dl
- Preferred monitoring: Postprandial Blood Glucose
- Post-prandial Blood Glucose Monitoring preferred
- Associated with improved outcomes
- Lower Hemoglobin A1C levels
- Lower birth weights
- Fewer cesarean sections
- References
- De Veciana (1995) N Engl J Med 333:1237
- Initial Evaluation
- Diabetic diet
- Diabetic nurse consultation
- Initiate home Blood Sugar Monitoring
- See Blood Glucose Monitoring above
- Management: Diet controlled management
- Indications
- Blood sugars within target range (see above)
- Monitoring
- See Blood Glucose Monitoring above
- Dietary recommendations
- Restrict carbohydrates to <40% of daily calories
- Caloric restriction if BMI > 30 kg/m2
- Limit to 25 KCal/kg of actual weight per day
- Avoid severe caloric restriction
- Ketonemia associated with psychomotor delay
- Rizzo (1995) Am J Obstet Gynecol 173:1753
- Exercise recommendations
- Regular aerobic Exercise improves glycemic control
- Circuit Resistance Training improves glycemic control
- Brankston (2004) Am J Obstet 190:188
- Management: Insulin controlled
- Indications
- Failed diet control
- Fasting Blood Glucose > 95 mg/dl or
- Two hour postprandial Blood Glucose >120 mg/dl
- Preexisting Insulin Dependent Diabetes Mellitus
- Protocol
- See Insulin Management in Pregnancy
- Endocrine consult as needed for Insulin Dosing
- New protocols (Experimental - not to be used in practice)
- Glyburide is only hypoglycemic not contraindicated
- ACOG and ADA do not recommend use until further RCT
- Glucophage is also being studied in pregnancy
- Glueck (2002) Hum Reprod 17:2858
- Pregnancy in Metabolic Syndrome on Metformin: 42%
- If occurs on Metformin, continue for first 20 weeks
- Prevents Rebound Hyperglycemia
- Second Generation Sulfonylureas experimentally used
- Blood sugar controlled as well as Insulin
- Markedly reduced Hypoglycemia with Oral Hypoglycemic
- No increased fetal anomaly or perinatal death
- References
- Greene (2000) N Engl J Med 343:1178
- Langer (2000) N Engl J Med 343:1134
- Antepartum aggressive monitoring for complications
- Weekly monitoring starting at 32 weeks gestation
- Non-Stress Test
- Some protocols include Biophysical Profile
- Daily Fetal Kick Counts starting at 34 weeks gestation
- Obstetric Ultrasound monthly
- Assess Fetal Growth
- Prenatal Visit frequency based on Blood Sugar control
- Plan Labor Induction by 39-40 weeks
- Intrapartum Management
- See Insulin Management in Labor
- Timing of delivery
- Consider offering Cesarean section for EFW > 4500 g
- Delivery prior to 40 weeks not indicated unless
- Poor glycemic control
- Other fetal or maternal complications
- Postpartum Care
- Consider Glucose Tolerance Test 2 hour (75 g Glucola)
- Non-Lactating: Schedule at 6 weeks to 3 months
- Breast Feeding: Schedule at 6 months
- Fasting Blood Glucose yearly
- Maintain ideal body weight
- References
- Turok (2003) Am Fam Physician 68(9):1767
Navigation Tree